News | RIVM

More than two million invitations to get vaccinated against HPV in 2023

In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.

Safety of materials and products already starts at the design phase

The Ministry of Infrastructure and Water Management aims to ensure that all new materials and technological developments are safe in 2050.

Onderzoeker met veiligheidsbril bekijkt preparaat

Health effects due to titanium nanoparticles in food and toothpaste cannot be excluded

Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.

Tool for risk assessment of nanomaterials in cosmetics

Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.

Nanotechnology increasingly used in medical devices

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

Cost-effective risk assessment of nanomaterials may be feasible

Companies, authorities and scientists can save time, money and test animals in the risk assessment of nanomaterials by using available data.

Innovation required in risk assessment of nanoparticles

The currently existing models and techniques provide insufficient certainties in the assessment of the harmfulness of nanoparticles and nanomaterials to people and the environment.

RIVM film about nanomaterials

RIVM contributes to the safe use of nanomaterials through research, alerts and policy consultations, and this work is demonstrated in a short informative film.

RIVM to research safe design for new nanoparticles

RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.

Nanotechnology in the fight against cancer

Nanotechnology offers improved options for the diagnosis and treatment of cancer.